These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7188115)

  • 1. [Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy].
    Perego MA; Sergio G; Artale F
    Ric Clin Lab; 1981; 11 Suppl 1():281-91. PubMed ID: 7188115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regional hemorheological effects induced by muscular exertion in peripheral obstructive arteriopathy. II].
    Perego MA; Sergio G; Espureo M; Giunti P; Francisci A; La Penna F; Artale F
    Minerva Cardioangiol; 1981; 29(7-8):375-82. PubMed ID: 7279238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
    Angelkort B
    Ric Clin Lab; 1981; 11 Suppl 1():215-21. PubMed ID: 7188109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regional study of the principal hemorheological factors in peripheral obstructive arteriopathy. I].
    Artale F; Sergio G; Espureo M; Giunti P; Francisci A; Perego MA
    Minerva Cardioangiol; 1981; 29(7-8):367-74. PubMed ID: 7279237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in systemic blood viscosity during induced intermittent claudication in peripheral obliterating arteriopathy].
    Forconi S; Guerrini M; Rossi C; Pecchi S; Di Perri T
    Boll Soc Ital Cardiol; 1977; 22(4):441-6. PubMed ID: 617290
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H; Anadere I; Heimburg P
    Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of arterial occlusive diseases].
    Hild R
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():95-105. PubMed ID: 4615466
    [No Abstract]   [Full Text] [Related]  

  • 12. [New possibilities in the rheologic-therapeutic influencing of blood viscosity in angiologic diseases].
    Ehrly AM; Glatz A; Scheinpflug W
    Verh Dtsch Ges Inn Med; 1974; 80():1450-2. PubMed ID: 4454453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical value of hemorrheology in peripheral arterial occlusive diseases].
    Sciannameo F; Francucci M; Cao PG; Giustozzi G; Valentini M; Tockner M; Sassano L; Grasselli A
    Ric Clin Lab; 1983; 13 Suppl 3():417-22. PubMed ID: 6673023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial occlusive disease: reducing blood viscosity through drugs].
    Gnauen H
    Med Klin; 1981 Feb; 76(5):144-6. PubMed ID: 7219342
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of CPD choline on a blood hyperviscosity syndrome secondary to chronic ischemic vasculopathy. Ex vivo study of clinical pharmacology].
    Auteri A; Pieragalli D; Blardi P
    Minerva Cardioangiol; 1984; 32(1-2):53-7. PubMed ID: 6717814
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific methods to determine hemorheological parameters.
    Kiesewetter H; Dauer U; Mussler K; Teitel P; Seiffge D; Schmid-Schönbein H
    Ric Clin Lab; 1981; 11 Suppl 1():125-33. PubMed ID: 7188105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic and haemorheological effects of buflomedil in patients with peripheral occlusive arterial disease.
    Perego MA; Sergio G; Espureo M; Francisci A; Artale F
    Curr Med Res Opin; 1982; 8(3):178-87. PubMed ID: 7128189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
    Mozzi E; Annoni F; Chiurazzi D; Rossi R; Pacini F; Martini A
    Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.